Comtech Telecommunications: A Long-Term Owner's Perspective

So on the question "is this a business I can understand and would still be happy to hold after the stock market closes for 5 years," my answer is: at the company level I can only give a below-average understandability score, while at the sub-business level the strength gap is pronounced. If I could own only Allerium, I would be more interested; if I had to own the entire listed entity under its current capital structure, I would not feel at ease. That distinction matters especially for a conservative investor.

Moat and Management

Start with the moat. Allerium's moat is clearly stronger than S&S's. Its advantage is not consumer brand mindshare but the switching costs of mission-critical infrastructure, compliance and standards capability, existing customer relationships, platform embeddedness, and ongoing operations capability. Across 2025 and the first two quarters of fiscal 2026, the company noted repeatedly that Allerium's growth comes from NG911 core-service upgrades, cloud-platform migration, location-product expansion, and state/provincial deployments; meanwhile, wins and renewals in the United States, Canada, and Australia show it is not a one-time box seller but a supplier embedded in public-safety communications workflows. For this kind of business, once deployed and running, customers do not switch easily.

But at the group level the moat is not wide. S&S has some barriers from technical qualifications, military-customer validation, product complexity, and defense and aerospace credentials — the company calls itself an important supplier of amplifiers, modems, and troposcatter technology, and lists orders from NASA, the U.S. Navy, the U.S. Army, and international government customers. But judged by economic results, those barriers have not yet translated into sustained high ROIC or stable free cash flow. Management even had to proactively cut more than 50% of slow-moving products and exit low-margin projects just to nurse S&S's quarterly operating profit from -$118.8 million in fiscal Q1 2025 up to +$3.3 million in Q4. That looks more like "repairing operating fundamentals" than "earning naturally off a moat."

My breakdown of the moat is as follows: brand advantage: weak; cost advantage: weak to medium; scale advantage: medium; network effects: weak; switching costs: Allerium medium to fairly strong; channel advantage: medium; patent/certification/qualification barriers: S&S medium; data advantage: Allerium has some but no overwhelming evidence; corporate culture/operating capability: under repair; capital-allocation capability: historically weak, somewhat improved now. Taken together, I give moat strength 2/5. The reason is simple: the moats that truly convince me should ultimately show up as high and durable returns on capital, stable cash flow, and pricing power in the face of inflation/recession — and Comtech has not produced that kind of scorecard over the past several years.

On management, I will not give a very low score, but I will certainly not give a high one. The execution since Ken Traub took over is one of the company's most positive changes right now. Since laying out a clear transformation in October 2024, the company has advanced a strategic-alternatives review, product-line simplification, S&S reorganization, cost reduction, and liquidity repair, and in the 2025 annual report it removed the "substantial doubt about going concern" disclosure that had appeared for seven consecutive quarters. Improving gross margin in the first two quarters of fiscal 2026, the turn to positive operating cash flow, and Allerium's large funded contract win all show the turnaround is not just talk.

But judged by capital-allocation history, this company is far from an excellent capital allocator. The most direct evidence: goodwill fell from about $347.7 million in fiscal 2021 to $204.6 million as of January 31, 2026, including a $79.6 million goodwill impairment recognized in fiscal Q1 2025; free cash flow was negative in most years from fiscal 2021 to 2025; the share count rose from 26.25 million shares in fiscal 2021 to 29.68 million on a TTM basis, and shareholder returns over the past several years came more from "less dividend, less buyback, more financing and dilution" than from steady growth in intrinsic value per share. In March 2026 the company also filed a mixed-securities shelf of up to $125 million, which further raises potential dilution and refinancing risk.

On governance there are two more signals I dislike. First, management and the board went through clear turmoil over the past several years; the former CEO was terminated "for cause" with subsequent litigation/counterclaims, which says the organizational culture and governance history have not been smooth. Second, as of January 31, 2026, management still disclosed material weaknesses in internal control that have not yet been remediated, spanning risk assessment, monitoring, information and communication, control design, and the review of control execution; this does not deny the near-term operating improvement, but it reminds investors that the "credibility premium" on financial quality still takes time to rebuild. So I give management and capital allocation 3/5, but more precisely it is "current management's execution is improving, while the long-term capital-allocation record remains subpar."

Financial Quality and Owner Earnings

Start with the big five-year trend. Comtech's financial trajectory is not pretty: revenue has not grown durably, margins have been chronically impaired, and free cash flow was negative in most years. Per the StockAnalysis/Fiscal.ai annual tables, fiscal 2021–2025 revenue was $581.7 million, $486.2 million, $550.0 million, $540.4 million, and $499.5 million; operating cash flow was -$40.64 million, $2.0 million, -$4.43 million, -$54.5 million, and -$8.29 million; free cash flow was -$56.68 million, -$17.62 million, -$22.74 million, -$67.58 million, and -$16.86 million. This is not a steady cash machine but a business that clearly ran off the rails for several years and only recently began to repair.

The annual figures above come mainly from the revenue, cash-flow, and segment-revenue pages of StockAnalysis/Fiscal.ai; the first-two-quarter fiscal 2026 figures come from the company's fiscal Q2 2026 SEC Exhibit 99.1 schedules.

The most important thing in this table is not that "the first two quarters of fiscal 2026 got better," but why they got better. The company's revenue for the first two quarters of fiscal 2026 was $217.8 million, gross profit $72.99 million, operating loss just $3.99 million, operating cash flow $12.95 million, and capex $7.68 million. That is a clear improvement. But a meaningful portion of the cash-flow improvement came from receivables collection and inventory release: in just six months, a decline in accounts receivable brought in $17.51 million of cash, and a decline in inventory brought in $1.96 million; at the same time, changes in contract liabilities, accounts payable, and accrued liabilities consumed some of that cash. This means the recent free-cash-flow improvement reflects both operating improvement and working-capital release, and you cannot simply treat the current cash flow as a long-term steady state.

On returns, the company has been subpar for a long time. Per the historical ratio table, ROIC for FY2021–FY2025 was roughly -8.32%, -3.62%, -1.50%, -9.83%, and -19.98%; on the latest reported basis, trailing-12-month ROIC is about 2.33%, still far below the corresponding WACC of 14.72%. That sentence is crucial: even with operations clearly improved versus last year, the company is still a long way from "creating value above its cost of capital." For a long-term value investor, that means what you buy today is not a proven high-return business.

The balance sheet is one of the worst features of this case. On January 31, 2026, cash on hand was $32.83 million, credit-facility borrowings plus the subordinated credit instrument totaled over $215 million on a carrying basis, on top of a $213.4 million liquidation preference on the convertible preferred; in the fiscal Q2 2026 results the company separately disclosed an additional $32.5 million make-whole amount associated with the subordinated instrument. Liquidity did improve to $49.9 million (including available revolver capacity), and financial-covenant testing has been waived through the quarter containing January 31, 2027 — but this is not a "sound balance sheet," it is a balance sheet that has temporarily stepped back from extreme stress while still operating under high pressure. Meanwhile, an Altman Z-Score of just 0.93 also signals that bankruptcy/restructuring sensitivity cannot be ignored.

Now to "are the profits real or not." I have seen no direct evidence of financial fraud, but I see three points that demand heightened caution. First, over the past several years GAAP profit has been heavily distorted by impairments, derivative/warrant fair-value changes, preferred-related accounting treatment, and amortization of financing costs, raising the reading threshold. Second, part of the recent cash-flow improvement came from working-capital release rather than pure operating-profit gains. Third, the material weaknesses in internal control have not been fully remediated. So my assessment is: there is no clear evidence of fraud, but accounting complexity is high, the statements are hard to read, and common shareholders need to apply stricter normalization to "cash profit."

On that basis, I take a notably conservative approach to estimating "Owner Earnings." On the surface, trailing-12-month operating cash flow is about $26.69 million and capex about $12.18 million, for free cash flow of about $14.51 million, which against the market cap at the current price puts the stock at roughly 11.9x P/FCF. But that misleads you, because the last twelve months of cash flow include a fair amount of working-capital release. Adjusting that back, and considering that the company is still in transformation, carries a heavy interest burden, and has not finished its restructuring cash outflows, I would rather peg normalized Owner Earnings to common at roughly $7 million to $10 million per year; if the transformation goes well, S&S moves into a higher-margin production phase, and Allerium keeps expanding recurring revenue, that could be revised up to $15 million to $16 million. Correspondingly, the "normalized owner-earnings multiple" at the current price is closer to 17x to 25x, not 12x.

What must be stressed especially: between the enterprise and the common stock sits a thick layer of debt and preferred. Even if Owner Earnings at the company level can hold near $15 million, the common is still a highly leveraged residual claim. So the statement "free cash flow approximates net income" does not matter much for CMTL; what matters more is how much of that cash flow ultimately lands "safely and reliably" in common shareholders' hands. On that point, my answer remains: it is too early to be optimistic.

Intrinsic Value and Margin of Safety

I will value CMTL three ways, but let me put the conclusion up front: the traditional "low multiple = undervalued" intuition is very dangerous on this stock. Because many of the low valuation metrics you see are in fact distorted by capital-structure complexity, working-capital release, and the preferred's liquidation preference.

Method One: Conservative Owner-Earnings discount from the common-equity perspective

I did not directly use the company's surface TTM FCF of $14.51 million as a starting point; I marked it down. The reasoning: the last twelve months of cash flow clearly benefited from declines in receivables and inventory, and that release cannot repeat indefinitely; at the same time, the company carries a heavy interest burden and a complex capital structure, and there were still restructuring-related cash outflows in recent quarters. On that basis I use the following three sets of normalized owner-earnings-to-common assumptions:

These ranges are not "precise values"; they are meant to reflect a more important reality: only in the optimistic case can the current $5.80 be called close to fair; in the neutral and conservative cases, the current price has no margin of safety. On this basis, the current price sits at a large premium to the conservative intrinsic-value range, at the high end of or slightly above the fair intrinsic-value range, and leaves only slight room in the optimistic case.

Method Two: Relative valuation

On the surface, CMTL's valuation looks very low: P/S 0.36, EV/S 0.83, P/FCF 11.88, EV/EBITDA 8.93. Looking at those multiples alone, you would think it is meaningfully cheaper than peers. But after comparing with peers, the conclusion is less simple. Aviat Networks (AVNW) has EV/EBITDA around 8.48, EV/S around 0.61, ROIC around 4.05%; Gilat (GILT) has EV/EBITDA around 20.96, EV/S around 2.27, ROIC around 7.47%; Viasat (VSAT) has EV/EBITDA around 10.63, EV/S around 3.26, ROIC around 0.04%; Motorola Solutions (MSI) has EV/EBITDA around 22.23, EV/S around 6.54, ROIC around 20.90%. By comparison, CMTL's problem is this: it looks cheap, but the quality is not impressive; its EV/EBITDA is no longer much cheaper than some higher-quality smaller peers, while its return on capital and balance sheet are worse.

In other words, CMTL's "low P/S" is not a gift from a moat but more like the capital market's discount for its fragile capital structure, low ROIC, and history of execution failure. Such discounts can sometimes offer opportunity, but only if you are confident the company has crossed an inflection point. On the current evidence, all I can say is that it is trying to cross it — far from "has already crossed."

Method Three: Asset and liquidation value

If we fall back on asset-floor valuation, the protection for the common is even weaker. On January 31, 2026, common shareholders' equity was only $65.61 million; the same day, goodwill was $204.6 million and finite-lived intangibles were $163.0 million, which together far exceed common equity, meaning tangible common equity is deeply negative. Factoring in a $213.4 million preferred liquidation preference and more than $227 million in credit-instrument borrowings, the liquidation protection for the common is almost unreliable. Unless Allerium or other assets are acquired at a high premium in a strategic sale, the notion of a "book-asset floor" does not hold for the common.

Pulling the three methods together, the range I give is:

On that basis, the current $5.80 carries no adequate margin of safety for a conservative long-term investor. More precisely, it already requires you to believe in advance that Allerium will keep growing, that S&S will complete the switch from low-margin development projects to higher-margin production orders, that the financing structure will not further harm the common, and that management will genuinely cement the recent improvements. That chain of assumptions is too long.

Risks, the Bear Case, and Alternatives

In my view, CMTL's risk is not "high volatility" but "it can easily produce a permanent loss of capital." The most important risks fall into six categories.

The first is capital-structure risk. Behind today's common stock stands a large amount of debt and preferred. On January 31, 2026, and March 13, 2026, the company disclosed a convertible-preferred liquidation preference of about $213.4 million to $215.7 million, credit-instrument outstanding balances over $227 million, and a make-whole amount attached to part of the subordinated financing. As long as operations fall even slightly short, you could see refinancing, asset sales, term amendments, or even dilutive financing — and the common is usually the last layer to bear the cost.

The second is Allerium's customer-concentration and renewal risk. The company has repeatedly mentioned that the "largest customer" granted a multi-year contract extension, with a single additional funding tranche of more than $107 million in fiscal Q2 2026. That certainly shows the customer relationship is strong, but conversely it also means that if that customer's budget, procurement strategy, or supplier preference changes, Allerium's value would take a significant hit. Based on current materials, I cannot confirm the exact percentage that the "largest customer" represents, so this is a core uncertainty that must be tracked continuously.

The third is S&S transformation-delivery risk. Management is explicit: S&S is exiting low-margin, working-capital-intensive businesses and pivoting toward higher-margin modems, network solutions, and multipath radios, expecting more production-type orders to land in fiscal 2026. But across the first two quarters of fiscal 2026, S&S orders and revenue were still clearly affected by government shutdowns, project cadence, and the wind-down of old contracts. If this transformation merely "cuts revenue" without effectively "lifting profit and cash conversion," the valuation logic gets overturned.

The fourth is accounting and internal-control risk. As of January 31, 2026, management still disclosed that material weaknesses in internal control had not been fully remediated. This does not mean the financials must be wrong, but for common shareholders it raises the return you should demand, because the "discount for the sustainability and verifiability of the financial figures" has not yet cleared.

The fifth is potential dilution risk. In March 2026 the company filed a shelf registration to sell various types of securities for up to $125 million in total. For a cash-rich, lightly indebted company this is not necessarily bad; but for a company like CMTL whose capital structure is already very heavy, it means common shareholders must always guard against "being further diluted to bail out or restructure the capital structure."

The sixth is the "good assets swallowed by a bad structure" risk. My strongest bear point is this: Allerium may genuinely be a good asset, but the common does not necessarily get to enjoy all of its value. If the company in the future sells quality assets to ease the debt and preferred layers, the common, while not necessarily zeroed, might receive only very limited residual value. For a conservative value investor, this is a very typical and very deadly structural risk. This judgment is an inference drawn from the company's current capital structure and asset composition, not a prediction of any specific transaction.

Which facts would overturn the investment thesis? I would watch five things: Allerium's book-to-bill below 1 for several consecutive quarters with loss of large-customer support; the quarterly operating improvement at S&S reversing again; operating cash flow turning negative again after stripping out working-capital release; a large dilutive financing or a recapitalization on worse terms; the material weaknesses in internal control still not substantively remediated after FY2026. If two or three of these happen at once, I would mark down the "the turnaround can succeed" assumption sharply.

Against the alternatives, CMTL's disadvantages are more pronounced. Versus Motorola Solutions, which is expensively valued but genuinely has high ROIC, high free cash flow, and a clearer public-safety moat; versus Aviat, where CMTL's EV/EBITDA is not much cheaper but the financial burden is heavier; versus passive ownership of the S&P 500 represented by SPY, where CMTL is not a "clearly superior" long-term holding; versus the roughly 4.46% yield-to-maturity on the U.S. 10-year Treasury, where CMTL must offer a very high excess return to justify its structural risk — and on my neutral valuation above, the current price does not provide that compensation. On the question "if I could hold only 5 assets, is it worth a slot," my answer is: not worth it.

Checklist and Final Investment Conclusion

First, the simplified checklist. To stay close to the format you specified, I answer with "Pass / Fail / Uncertain."

【Final Rating】 Avoid

【One-Sentence Investment Thesis】 CMTL may be able to fix the operations, but at the common-equity level a complex capital structure and a not-strong-enough business quality have already turned "investing" into a bet on the outcomes of the turnaround and the financing.

【Core Bull Points】

• The NG911 / public-safety communications track that Allerium sits in has long-term institutionalized demand, supported by FCC rules, NTIA investment, and the advance of industry standards.

• Operating quality improved markedly in the first two quarters of fiscal 2026, with gross margin and operating cash flow trending up, showing the new management's cleanup is not empty talk.

• In fiscal Q2 2026 Allerium won a large multi-year extension funding from its largest customer, showing the customer relationship and platform embeddedness still hold value.

• If S&S genuinely completes the switch from low-margin development projects to higher-margin production orders, margins and cash conversion could keep improving.

【Core Bear Points】

• Behind the common stand a large amount of debt, subordinated debt, and a preferred liquidation preference, leaving the residual interest very fragile.

• The historical ROIC, free cash flow, and capital-allocation records are all poor, showing this is not an already-proven, high-quality compounder.

• The recent cash-flow improvement includes a fair amount of working-capital release, so true steady-state Owner Earnings may be below the surface FCF.

• The material weaknesses in internal control are still being remediated; governance and financial credibility have not been fully repaired.

• The March 2026 shelf registration leaves subsequent dilution risk perpetually hanging over the common.

【Key Assumptions】 For this investment to work, at minimum the following must all hold: Allerium maintains growth and renews successfully; S&S's high-margin product switch lands in FY2026–FY2027; operating cash flow no longer depends mainly on working-capital release; the financing structure does not come at the cost of heavily harming the common; the internal-control problems are substantively remediated.

【Fair Buy Price】 For a conservative investor, I think the more attractive entry sits in the $2 to $3.5 range; $3 to $5 can be viewed as a "barely discussable holding range"; $5.8 is no longer a margin-of-safety entry.

【Target Holding Period】 If you really participate, I would not treat it as a "buy and forget for 10 years" asset either, but more as a special-situation stock that needs quarterly verification of turnaround evidence. For the vast majority of long-term value investors, it does not meet the precondition of "can be comfortably held for the long term."

【Expected Annualized Return】

• Conservative case: -8% to -12%, corresponding to a failed turnaround, dilutive financing, or quality-asset value swallowed by the capital structure.

• Neutral case: 2% to 6%, corresponding to continued operating improvement that is not enough to give the common a clear value re-rating.

• Optimistic case: 10% to 14%, corresponding to Allerium maintaining high-quality growth, S&S successfully repairing, and the capital structure being smoothly simplified. The enormous dispersion across these return ranges is itself proof that it does not suit a conservative long-term core position.

【Maximum Loss Risk】 A 70% to 100% permanent loss of capital is no exaggeration. Once operating improvement stalls, customer concentration is exposed, refinancing terms worsen, or the preferred/debt layers take value first, the common may have only a tiny residual left.

【Tracking Metrics】 I suggest tracking continuously: Allerium revenue and book-to-bill, S&S operating margin, operating cash flow after stripping out working-capital changes, total liquidity, actual debt balance, changes in the preferred liquidation preference, whether new securities are issued via S-3, the remediation progress of the material weaknesses in internal control, the largest customer's renewal/additional funding, and the conversion rate of backlog into revenue visibility.

【Signals That Trigger Re-Assessment】 If any of the following occurs, I would immediately re-examine the investment logic: Allerium's growth clearly stalls; S&S again posts a large project loss or inventory write-down; operating cash flow turns negative when working capital is not helping; new high-cost financing or a large dilutive issuance; the preferred terms trigger more adverse consequences; the internal-control weaknesses persist for a long time.

【Final Recommendation】 Calmly and with restraint: I do not recommend CMTL as a long-term value investment for your risk profile. It now looks more like a combination problem of "operating repair plus a capital-structure game" than a good business already proven to produce high-quality cash flow steadily over the long run. If you absolutely must participate, it is best to wait until the price is lower, or the capital structure is clearer, or operating improvement converts into "real cash profit after stripping out the working-capital effect" for several consecutive quarters. Until then, putting it on a watch list is more sensible than putting it in a core position.

Open questions and limitations: This report has prioritized the company's latest quarterly/annual materials, SEC Exhibits/10-Qs, and authoritative market data; but on the largest customer's exact revenue share, the personal-shareholding details of current core executives, and the full economic consequences of the preferred across different control-change scenarios, the verified materials available remain insufficient, and the related conclusions should be viewed as conservative framework judgments rather than a final quantitative verdict on these specifics.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.